Tag: Grail
FTC Orders Illumina To Divest GRAIL To Protect Competition
The Federal Trade Commission has issued an Opinion and Order mandating that Illumina, a DNA sequencing provider, divest GRAIL, which produces a multi-cancer early...
EU Orders Illumina To Keep Grail As A Separate Entity
EU antitrust regulators on Friday renewed interim measures ordering US life sciences company Illumina to keep Grail as a separate entity pending an order...
EU To Rule On Illumina’s Challenge Of EU Review Of Grail...
A European court will decide on July 13 whether US life sciences company Illumina’s $8 billion cash-and-stock takeover of Grail should be scrutinised by...
EU Not Convinced On Illumina Remedies For Grail Bid
US life sciences company Illumina's offer to cut prices and allow rivals continued access to its technologies has "yet to convince" EU antitrust regulators...
EU Watchdog Pauses Illumina, Grail Probe Again
EU antitrust regulators have temporarily paused their investigation into US life sciences company Illumina bid for $8 billion cash-and-stock takeover of Grail while waiting...
Illumina Offers Concessions To EU Over $8B Grail Deal
Illumina has offered to cut prices and continue to allow rivals access to its technologies in a bid to allay EU antitrust concerns about...
EU Antitrust Regulators Re-Start Illumina, Grail Probe
EU antitrust regulators have resumed their scrutiny of US life sciences company Illumina’s bid for Grail after a two-month temporary halt and will decide...
EU Probes Illumina’s $7.1B Grail Acquisition
EU antitrust regulators will examine Illumina’s proposed US$7.1 billion acquisition of cancer test maker, the European Commission announced on Tuesday, April 20, following a...
